The risk factors of liver metastasis (LM) in patients with non-small-cell lung cancer (NSCLC) remain unknown. Whether LM predicts the effect of first-line EGFR-tyrosine kinase inhibitors (TKIs) in patients with EGFR-mutant NSCLC needs to be explored.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qMQmm3
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Background Hyperthyroidism is associated with increased thrombotic risk. As contact system activation through formation of neutrophil extrac...
-
UM-Chor1: establishment and characterization of the first validated clival chordoma cell line. J Neurosurg. 2017 Apr 21;:1-9 Authors:...
-
Publication date: Available online 10 May 2017 Source: Journal of Dairy Science Author(s): R.E. Vibart, M. Tavendale, D. Otter, B.H. Schw...
-
Abstract Inadequate post-operative pain management can have significant impacts on patients' quality of life. Effective management of ...
-
Abstract Background Cancer patients suffer in part because some health professionals prescribe or administer amounts of analgesics, namely...
-
Abstract Purpose Studies on preemptive analgesia in maxillofacial surgery have shown several controversial clinical results, mainly due to...
-
Special Issue for Papers Presented at the Annual Meeting of the German Audiology and Neurootology Group 2014 (ADANO) in Dresden/Germany No a...
-
Randomized trial of transcranial DC stimulation for post-stroke dysphagia. Ann Neurol. 2018 Jan 19;: Authors: Suntrup-Krueger S, Ring...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου